ING Group, N.V. News Headlines

IND 
$25.49
*  
0.01
0.04%
Get IND Alerts
*Delayed - data as of Oct. 20, 2014 13:52 ET  -  Find a broker to begin trading IND now
Exchange: NYSE
Industry: Finance
Community Rating:
View:    IND Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Patients Enrolled in Avanir Study - Analyst Blog
6/2/2014 5:35:00 PM - Zacks.com


Pipeline Update from Avanir - Analyst Blog
6/2/2014 5:00:00 PM - Zacks.com


Oncothyreon Collaborates with Celldex - Analyst Blog
5/30/2014 4:40:00 PM - Zacks.com


ZIOPHARM Presents Encouraging Data - Analyst Blog
5/23/2014 5:48:00 PM - Zacks.com


XenoPort's Q1 Loss Narrows - Analyst Blog
5/14/2014 2:17:00 PM - Zacks.com


Apricus' Q1 Loss Narrows - Analyst Blog
5/13/2014 11:15:00 AM - Zacks.com


Pipeline Progress at Coronado Biosciences - Analyst Blog
4/14/2014 5:20:01 PM - Zacks.com


Sector Update: Healthcare Shares Mixed Pre-Market; Vivus Sinks 5% on Piper Jaffray Downgrade
4/3/2014 8:35:37 AM - MT Newswires


Sector Update: Healthcares
4/3/2014 8:30:19 AM - MT Newswires


Fate Reports In-Line Loss in Q4 - Analyst Blog
3/20/2014 2:28:01 PM - Zacks.com


Repros Provides Proellex Update - Analyst Blog
3/18/2014 5:10:01 PM - Zacks.com


Charles River Acquires CRO Division of Galapagos - Analyst Blog
3/14/2014 5:40:01 PM - Zacks.com


Progenics Q4 Loss Narrower Than Expected - Analyst Blog
3/14/2014 11:40:01 AM - Zacks.com


Geron Plunges on FDA Clinical Hold - Analyst Blog
3/13/2014 1:10:01 PM - Zacks.com


Fate Therapeutics' Prohema in Phase II Study - Analyst Blog
3/13/2014 11:50:01 AM - Zacks.com


ProAssurance Corporation (PRA): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
3/13/2014 8:00:01 AM - Zacks.com


Alcobra Gains IND Clearance for MDX - Analyst Blog
3/7/2014 7:40:01 PM - Zacks.com


XenoPort's 4Q Loss Narrower-Than-Expected - Analyst Blog
2/21/2014 12:22:01 PM - Zacks.com


Positive News for Regado's REG2 - Analyst Blog
2/14/2014 6:40:01 PM - Zacks.com


Biodel Q1 Loss Narrows - Analyst Blog
2/10/2014 3:49:01 PM - Zacks.com


Pipeline Progress at Galectin Therapeutics - Analyst Blog
2/5/2014 6:30:01 PM - Zacks.com


Pipeline Update from XenoPort - Analyst Blog
1/16/2014 7:50:01 PM - Zacks.com


Pipeline Progress at BioMarin - Analyst Blog
1/15/2014 7:20:01 PM - Zacks.com


Pipeline Update at Alnylam - Analyst Blog
1/13/2014 7:20:01 PM - Zacks.com


Sangamo and Biogen Tie Up - Analyst Blog
1/13/2014 6:12:01 PM - Zacks.com